Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
10,434
-5,207
-33% -$174K ﹤0.01% 3770
2026
Q1
$469K Sell
15,641
-178,411
-92% -$4.17M ﹤0.01% 3609
2025
Q4
$4.41M Buy
194,052
+3,440
+2% +$92.8K ﹤0.01% 2528
2025
Q3
$5.31M Sell
190,612
-131,955
-41% -$4.14M ﹤0.01% 2408
2025
Q2
$11.8M Buy
322,567
+5,514
+2% +$258K ﹤0.01% 1692
2025
Q1
$13.4M Buy
317,053
+132,407
+72% +$7.75M ﹤0.01% 1560
2024
Q4
$12M Buy
184,646
+3,070
+2% +$213K ﹤0.01% 1663
2024
Q3
$11.2M Buy
+181,576
New +$11M ﹤0.01% 1689

Other funds holding IBTA

Ameriprise's IBTA Position: Q2 2026 in Review

Ameriprise reduced its Ibotta (IBTA) stake by 33% in Q2 2026, selling an estimated $174K and leaving 10,434 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Ameriprise first reported a position in IBTA in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.4M in Q1 2025. 146 funds tracked by Wall St. Rank hold IBTA as of Q2 2026.

  • Ameriprise held 10,434 shares of Ibotta worth $356K as of Q2 2026.
  • Ameriprise sold 5,207 Ibotta shares in Q2 2026, an estimated $174K.
  • Ibotta made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3770 holding.
  • Ameriprise first reported a position in Ibotta in Q3 2024 and has held it in 8 quarters since.
  • Ameriprise's Ibotta position peaked at $13.4M in Q1 2025.
  • 146 funds tracked by Wall St. Rank held Ibotta as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.